These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25371068)

  • 1. Cardiomyopathy in murine models of systemic sclerosis.
    Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
    Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
    Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
    Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
    Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
    Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
    Maurer B; Reich N; Juengel A; Kriegsmann J; Gay RE; Schett G; Michel BA; Gay S; Distler JH; Distler O
    Ann Rheum Dis; 2012 Aug; 71(8):1382-7. PubMed ID: 22523431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in animal models of systemic sclerosis.
    Asano Y
    J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
    Maurer B; Busch N; Jüngel A; Pileckyte M; Gay RE; Michel BA; Schett G; Gay S; Distler J; Distler O
    Circulation; 2009 Dec; 120(23):2367-76. PubMed ID: 19933934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
    Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
    Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
    Tsujino K; Reed NI; Atakilit A; Ren X; Sheppard D
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L22-L31. PubMed ID: 27864286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fra-2 transgenic mouse model of systemic sclerosis.
    Maurer B; Distler JH; Distler O
    Vascul Pharmacol; 2013 Mar; 58(3):194-201. PubMed ID: 23232070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of scleroderma: fresh insights.
    Artlett CM
    Curr Opin Rheumatol; 2010 Nov; 22(6):677-82. PubMed ID: 20720495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
    Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary myocardial involvement in systemic sclerosis.
    Kahan A; Allanore Y
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E; Borys O; Błaszczak P; Majdan M
    Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold capillary abnormalities in sclerodermatous chronic GVHD.
    Hofstee HM; de Waal TT; Zweegman S; Voskuyl AE; Smulders YM; Schoordijk MC; Janssen JJ; Serné EH
    Bone Marrow Transplant; 2013 Nov; 48(12):1574-7. PubMed ID: 23892332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
    Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
    Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.
    Tzelepis GE; Kelekis NL; Plastiras SC; Mitseas P; Economopoulos N; Kampolis C; Gialafos EJ; Moyssakis I; Moutsopoulos HM
    Arthritis Rheum; 2007 Nov; 56(11):3827-36. PubMed ID: 17968945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.
    Sandmeier B; Jäger VK; Nagy G; Carreira PE; Tzankov A; Widuchowska M; Antic M; Distler O; Reichert H; Distler JH; Walker UA; Hügle T
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S75-9. PubMed ID: 26339891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.